Elevra Lithium signs 240,000-dmt spodumene supply deal with LG Energy Solution
Bitget2026/10/08 13:02Elevra Lithium signed a binding spodumene concentrate supply agreement with LG Energy Solution for output from its Québec NAL operation. Contracted volumes total 240,000 dmt over three years from first shipment, expected in calendar 2026. Deal includes up to 90,000 dmt of optional volume, subject to mutual agreement. Pricing is market-linked, adjusted for lithium content. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080900PRIMZONECNPR____9841837) on October 08, 2026, and is solely responsible for the information contained therein.
- Elevra Lithium signed a binding spodumene concentrate supply agreement with LG Energy Solution for output from its Québec NAL operation.
- Contracted volumes total 240,000 dmt over three years from first shipment, expected in calendar 2026.
- Deal includes up to 90,000 dmt of optional volume, subject to mutual agreement.
- Pricing is market-linked, adjusted for lithium content.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
